ANDA 78861, held by Aurobindo Pharma. Sertraline Hydrochloride.
As of Nov 16, 2026, ANDA 78861 (Sertraline Hydrochloride), held by Aurobindo Pharma, was first approved by FDA on Oct 31, 2008, with 9 approved supplements and 0 published complete response letters.
Sertraline hydrochloride oral solution is indicated for the treatment of the following: Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride oral solution is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of: Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD)
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sertraline HydrochlorideEQ 20MG BASE/ML · concentrate;oral | Sertraline Hydrochloride | Rx |
| Feb 2, 2024 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jun 8, 2023 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jun 8, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jan 31, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 31, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Aug 3, 2017 | Supplement 5Manufacturing | Approved | None posted |
| Aug 3, 2017 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jan 29, 2013 | Supplement 4Labeling | Approved | None posted |
| Feb 25, 2009 | Supplement 1Labeling | Approved | None posted |
| Oct 31, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters